FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 103 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $264,000 | -98.2% | 7,016 | -99.2% | 0.00% | -100.0% |
| Q4 2020 | $14,330,000 | +55015.4% | 842,431 | +7007.9% | 0.02% | – |
| Q1 2020 | $26,000 | +23.8% | 11,852 | +119.9% | 0.00% | – |
| Q3 2019 | $21,000 | -99.9% | 5,390 | -99.5% | 0.00% | -100.0% |
| Q2 2018 | $17,434,000 | -4.9% | 1,102,760 | +3.3% | 0.04% | -7.5% |
| Q1 2018 | $18,332,000 | -9.5% | 1,067,090 | +15.5% | 0.04% | -7.0% |
| Q4 2017 | $20,258,000 | -7.0% | 924,190 | +73.5% | 0.04% | -12.2% |
| Q3 2017 | $21,790,000 | +8.6% | 532,640 | -20.1% | 0.05% | +4.3% |
| Q2 2017 | $20,066,000 | +7.3% | 666,440 | +28.9% | 0.05% | +6.8% |
| Q1 2017 | $18,693,000 | -21.5% | 517,100 | +8.8% | 0.04% | -26.7% |
| Q4 2016 | $23,821,000 | -22.9% | 475,383 | -19.3% | 0.06% | -31.0% |
| Q3 2016 | $30,903,000 | – | 588,733 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|